In addition, the induction of IPPOL keratinocyte senescence or differentiation, as previously suggested by others based on a p53-deficient mouse liver cancer model [53], may aid therapeutic effectiveness of the targets mentioned above. The gene discussed is TP53; the disease is liver cancer.